Colin G. Sandercock's most recent trade in Cue Biopharma Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 05 Aug 2020 | 13,374 | 17,125 (0%) | 0% | 20 | 267,480 | Common Stock |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2020 | 13,374 | 130,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.50 per share. | 05 Aug 2020 | 13,374 | 30,499 (0%) | 0% | 7.5 | 100,305 | Common Stock |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.50 per share. | 03 Aug 2020 | 6,425 | 23,550 (0%) | 0% | 7.5 | 48,188 | Common Stock |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 03 Aug 2020 | 6,425 | 17,125 (0%) | 0% | 20 | 128,500 | Common Stock |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2020 | 6,425 | 143,575 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 03 Aug 2020 | 201 | 17,125 (0%) | 0% | 20.0 | 4,030 | Common Stock |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.50 per share. | 03 Aug 2020 | 201 | 17,326 (0%) | 0% | 7.5 | 1,508 | Common Stock |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, General Counsel and Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2020 | 201 | 143,374 | - | - | Stock Option (right to buy) |